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CC BY-NC-ND license (http://creativAbstract Whether low-concentration desflurane reinforces propofol-based intravenous
anesthesia on maintenance of anesthesia for patients undergoing laparoscopic cholecystec-
tomy is to be determined. The aim of this study was to investigate whether propofol-based
anesthesia adding low-concentration desflurane is feasible for laparoscopic cholecystectomy.
Fifty-two patients undergoing laparoscopic cholecystectomy were enrolled in the prospective,
randomized, clinical trial. Induction of anesthesia was achieved in all patients with fentanyl
2 mg/kg, lidocaine 1 mg/kg, propofol 2 mg/kg, and rocuronium 0.8 mg/kg to facilitate tracheal
intubation and to initiate propofol target-controlled infusion (TCI) to effect site concentration
(Ce: 4 mg/mL with infusion rate 400 mL/h). The patients were then allocated into either pro-
pofol TCI based (group P) or propofol TCI adding low-concentration desflurane (group PD) for
maintenance of anesthesia. The peri-anesthesia hemodynamic responses to stimuli were
measured. The perioperative psychomotor test included p-deletion test, minus calculation,
orientation, and alert/sedation scales. Group PD showed stable hemodynamic responses at
CO2 inflation, initial 15 minutes of operation, and recovery from general anesthesia as
compared with group P. There is no significant difference between the groups in operation
time and anesthesia time, perioperative psychomotor functional tests, postoperative vomit-
ing, and pain score. Based on our findings, the anesthetic technique combination propofoleclare no conflicts of interest.
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Desflurane reinforces propofol TCI 33and desflurane for the maintenance of general anesthesia for laparoscopic cholecystectomy
provided more stable hemodynamic responses than propofol alone. The combined regimen is
recommended for patients undergoing laparoscopic cholecystectomy.
Copyright ª 2016, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
Laparoscopic cholecystectomy (LC) provides patients less
postoperative pain, more rapid mobilization, faster return
to normal activities, and earlier hospital discharge as
compared to traditional open cholecystectomy [1e3], and
general anesthesia is the standardized anesthetic tech-
nique of choice for this procedure [4]. Desflurane has a
lower blood:gas solubility coefficient (0.47) than other
volatile anesthetics, and provides rapid induction and re-
covery from anesthesia [5,6]; however, desflurane easily
leaks out to the air and blunts the protective responses in
anesthetists and medical personnel who are exposed in the
environment. Hence, LC surgery under total intravenous
anesthesia (TIVA) was chosen as an alternate option. Pro-
pofol is a short-acting general anesthetic agent used widely
for TIVA because of the beneficial effects on antiemetic
properties and rapid recovery time [7,8]. For general
anesthesia, opioids given for the alleviation of surgical-
injury-induced pain also decrease the propofol dose or
decrease the inhaled anesthetics concentration, but inevi-
tably the decreased general anesthetics cannot ensure loss
of consciousness and lack of awareness [9,10]. Propofol and
desflurane are therefore suitable because of their recom-
mended pharmacological properties [11,12]. However,
propofol provides less potency, and the patient consumes
more opioids to relieve pain as compared to desflurane
[13]. Whether propofol target-controlled-infusion (TCI)
combination of low-concentration desflurane provides a
proper regimen for patients undergoing LC surgery is not
yet determined. We hypothesize that the regimen of pro-
pofol TCI adding low-concentration (3%) desflurane might
reinforce the anesthetic effect and provide better hemo-
dynamic stability for LC. The study was designed to assess
the feasibility of two propofol-based anesthetic regimens
(desflurane with propofol vs. propofol alone) with fixed
fentanyl continuous infusion to maintenance profile in pa-
tients undergoing LC.
Methods
The study was approved by the local Institutional Review
Board (KMUK-IRB-990201). Fifty-two American Society of
Anesthesiologists physical status I and II patients, aged
21e63 years, scheduled for elective LC, were enrolled in
this prospective, randomized, clinical study after their
written informed consents were obtained. The patients
were randomly assigned to one of the following two anes-
thesia groups for maintenance during operation: propofol
TCI and low-concentration desflurane (group PD), or pro-
pofol TCI alone (group P). The exclusion criteria were se-
vere systemic disease, morbid obesity, and patient refusal.According to the study protocol, standard monitoring
was installed upon arrival in the anesthetic room. Oxygen
was offered via an anesthetic breathing circuit and face-
mask. After 3-minute preoxygenation, the induction of
anesthesia was achieved in all patients with fentanyl 2 mg/
kg, lidocaine 1 mg/kg, propofol 2 mg/kg, and rocuronium
0.8 mg/kg to facilitate tracheal intubation and to initiate
propofol TCI (Ce: 4 mg/mL, infusion rate 400 mL/h) using a
TCI pump (EP-1809-1; Fresenius Kabi, Bad Homburg, Ger-
many) to blunt intubation-induced hemodynamic re-
sponses and to maintain general anesthesia. For the
maintenance of anesthesia, patients in group PD received
propofol TCI with fentanyl (1 mg/kg/h) and desflurane at
an end-tidal concentration of 3%. Patients in group P
received propofol TCI (Ce: 4 mg/mL) with fentanyl (1 mg/
kg/h). As compared with the baseline mean arterial pres-
sure (MAP) value, if hemodynamic responses deviate up
each 10% MAP values, increased propofol Ce level 0.5 and
fentanyl 0.5 mg bolus; if hemodynamic responses deviate
down 10% MAP values, decreased propofol Ce level 0.5 and
administered ephedrine 8 mg intravenously as over 20%
MAP dropped.
The primary outcome was measured by the hemody-
namic stability. The parameters of hemodynamic response
included heart rate and MAP; the response was measured
by heart rate and MAP difference from baseline value.
During anesthesia, hemodynamic responses to stimuli were
measured at each time point of pre-intubation as baseline
(PI), post-intubation (PoI), pre-CO2 insufflation (PC), post-
CO2 insufflation (PoC), operation time every 5 minutes to
35 minutes (Op5 to Op35), remove trocar (Rt), set Ce level
back to 2 (Ce2), stop propofol infusion (stop-P), sponta-
neous breathing (SB), and remove endotracheal tube
(Rendo). Perioperative psychomotor tests that included a p-
deletion test (a set time test in which patients identify the
p’s in lines of random letters), observer’s assessment of
alertness/sedation (OAA/S) scale (0e5), attention and
calculation (0e5), and orientation (0e10) were performed
at preoperation and 60 minutes after the end of surgery.
Following the end of surgery, postoperative pain, nausea
and vomiting, and complication were also assessed by the
unaware nurse assistant. All patients rated their post-
operative pain using a 10-point numeric rating scale (from
0 Z no pain to 10 Z worst pain). All postoperative obser-
vations were completed by the same nurse anesthetist who
was unaware to the study-grouping patients. Intravenous
ketorolac 30 mg was the first-line rescue analgesia, and
pethidine 50 mg was considered as the second rescue an-
algesics if needed. Postoperative nausea and vomiting
(PONV) was treated with metoclopramide as needed.
Resource utilization included anesthesia time, operation
time, and consumption of anesthetic agents.
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hemodynamic responses to surgical intervention as patients
undergoing LC with target-controlled propofol infusion.
Amean difference of 11MAP between groupswith a standard
deviation of 13mmHg revealed at least a group size of nZ 23
to detect a difference with a power of 0.8 at the a level of
0.05 [14]. Therefore, the study enrolled 26 patients in each
group (110% of the minimum required patients). Data are
presented as mean values and standard deviation. Differ-
ences and frequencies between groups were analyzed using
the Student t test or Pearsonc2 test as appropriate. A p value
< 0.05was considered statistically significant. The statistical
analyses for the study were performed using SPSS 12.0 for
Windows (SPSS Inc., 233 South Wacker Drive, 11th Floor
Chicago, IL 60606-6412).
Results
Fifty patients were into final analysis, including 26 patients
in group PD and 24 patients in group P. Two out of 26 pa-
tients in group P failed to allocate into analysis, one for
unexpected difficult intubation and the other one for un-
intentional intravenous set leaks (Figure 1).Figure 1. Flowcharts of patients undergoing laparoscopic cholec
controlled infusion.The MAP difference (each time-interval MAP value
minus baseline MAP value) shown in Figure 2 presents more
stable hemodynamic responses to various stimuli in group
PD than the hemodynamic responses in group P. There are
significant differences between groups at time intervals of
PoC (p < 0.05), Op5 (p < 0.01), Op10 (p < 0.01), Op15
(p < 0.05), Ce2 (p < 0.05), and Stop-P (p < 0.05). As
regards the heart-rate difference (each time interval
minus baseline), it presents more stability of heart rate in
group P than in group PD. There is a significant difference
between groups at PoC time interval.
There are no significant differences in demographic
characteristics, anesthetic time, operation time, and con-
sumption of anesthetic agents between groups (Tables 1
and 2). In addition, there is no significant difference on
perioperative psychomotor functional tests (Table 3), and
requirement of postoperative analgesia, pain score, and
incidence of PONV (Table 4) between groups.
Discussion
Previous studies focused on comparing propofol with inha-
lational agents; the advantages of propofol-based generalystectomy allocated either group PD or group P. TCI Z target-
Figure 2. Hemodynamic responses to various stimuli during peri-anesthesia period. Group PD presents mean arterial pressure
and heart rate more stable than group P at time intervals of PoC, Op5, Op10, Op15, Ce2, and stop-P, respectively. Ce2Z effect-site
concentrations of propofol back to 2; HR Z heart rate (beats/min); MAP Z mean arterial pressure (mmHg); Op5 to
Op35Z operation time every 5 minutes to 35 minutes; PCZ pre-CO2 insufflation; PIZ pre-intubation as baseline; PoCZ post-CO2
insufflation; PoIZ post-intubation; RendoZ remove endotracheal tube; RtZ remove trocar; SBZ spontaneous breathing; stop-
P Z stop propofol target-controlled infusion.
Desflurane reinforces propofol TCI 35anesthesia have become an alternative choice because of
its rapid clearance and improvements in well-being
[7,11,15]. In this study, the novel regimen still provides
the advantages of propofol-based general anesthesia for LC
patients, but limits use of opioid by instead using low-
concentration desflurane. Due to the primary outcome
measure of the hemodynamic stability between groups,
opioid consumptions between groups did not show statis-
tical difference. However, the authors believe that a larger
sample size of group patients would present the statistical
difference in propofol and opioid consumptions in group P
as compared with the group PD. The study simply demon-
strates that the regimen of propofol-based general anes-







Male 12 (46.2%) 7 (29.2%)
Female 14 (53.8%) 17 (70.8%)
Age (y) 44.15 (23e61) 47.13 (31e60) 0.295
Body mass
index (kg/m2)
25.55 (4.00) 24.29 (3.42) 0.240
ASA physical status (I/II) 0.954
Class I 1 (3.8%) 1 (4.2%)
Class II 25 (96.2%) 23 (95.8%)
Values are expressed as numbers (proportion), median (inter-
quartile range), or mean (standard deviation) as appropriate.
ASA Z American Society of Anesthesiologists.provides stable hemodynamics during the perioperative
period, but also reduces opioid and propofol consumption.
The present study found that patients undergoing LC
surgery with propofol-based general anesthesia adding low-
concentration desflurane had less MAP change at stages of
CO2 inflation (reverse Trendelenburg position and pneu-
moperitoneum), within 15 minutes of initiation of operation
(surgical stimuli), and recovery from general anesthesia
(withdrawal of propofol). In our study, the propofol TCI
with desflurane provided satisfactory anesthesia for LC and
smooth recovery when compared with propofol TCI alone.
With the addition of desflurane, a hemodynamic change in
TCI with propofol was attenuated. It may be related to the
vasodilation effect of desflurane, which resulted in dose-
dependent reductions in systemic vascular resistance and








102.24 (30.03) 103.40 (32.27) 0.183
Operation time
(min)
55.48 (25.41) 58.63 (26.48) 0.111
Fentanyl (mg) 125.17 (21.88) 138.11 (26.44) 0.070
Propofol (mg) 125.30 (21.75) 140.11 (29.76) 0.055
2% Xylocaine (mg) 62.65 (10.87) 69.09 (13.19) 0.071
Rocuronium (mg) 50.12 (8.70) 54.93 (10.46) 0.089
Values are expressed as mean (standard deviation).







Pre-op 44.6  9.1 44.8  7.5







Minus calculation (5/4-1/0) 0.316
Pre-op 26/0/0 24/0/0
Post-op 24/1/1 19/4/1
Postoperation: 60 minutes after the end of surgery.
OAA/S Z observer’s assessment of alertness/sedation scale;
Post-op Z post-operative; Pre-op Z pre-operative.
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except in the stage of post-CO2 inflation. However, the
rate-pressure product presents a similar trend between
groups. It validates that low-concentration desflurane
added to the regimen of propofol-based anesthesia
decreased the fentanyl and propofol dosages, but did not
increase the hemodynamic responses to surgical stimuli.
PONV is an important issue of patient satisfaction and is
a common phenomenon after laparoscopic procedures.
Prior studies have shown that TIVA reduces PONV compared
with volatile anesthesia [16e23]; however, there was no
significant difference between the two groups in our study.
The study results also showed that, when propofol TCI was
used as mainstay of anesthetic technique either with or
without desflurane, the PONV incidence was low. This
might be explained by the antiemetic effect of propofol
only required as low as 20e30 mg. Furthermore, low inci-
dence with propofol TCI was presented during the whole
course after operation. Nevertheless, the postoperative
pain and psychomotor status are similar.Table 4 Requirement of postoperative analgesia, pain







Ketorolac 15 (57.7%) 17 (70.8%)
Ketorolac þ pethidine 11 (42.3%) 7 (29.2%)
VAS 0.262
Score 1e3 10 (38.5%) 13 (54.2%)
Score 4e6 15 (57.7%) 11 (45.8%)
Score 7e10 1 (3.8%) 0 (0.0%)
PONV 0.954
None 25 (96.2%) 23 (95.8%)
Mild 1 (3.8%) 1 (4.2%)
Postoperation: 60 minutes after the end of surgery. Values are
expressed as numbers (proportion).
PONV Z postoperative nausea and vomiting; Post-op Z post-
operative; VAS Z visual analogue scale.There are several limitations in this study. First, since
desflurane was delivered via a vaporizer, a double-blind
strategy was unable to be performed in the study. Sec-
ond, we used fentanyl with propofol TCI instead of
remifentanil for the reason that we do not have remi-
fentanil in our hospital. Remifentanil is a m-opioid re-
ceptor agonist with a quick onset and peak effect, as well
as a short duration of postoperative activity, and may be
a better agent for short-duration surgery. Third, the
conscious-level monitor, such as entropy or bispectral
index, was not available during the study period, but
instead of maintaining stable hemodynamia during oper-
ation. Although we could not prove the same anesthetic
depth in both groups, those patients recovered without
explicit memory. In addition, regular anesthetic care was
delivered by a single experienced nurse anesthetist to
ensure the standardized anesthesia protocol.
In conclusion, propofol TCI with low-concentration des-
flurane for anesthesia maintenance provided more stable
hemodynamic responses than propofol TCI alone. The novel
regimen did not diminish the advantage of propofol TCI
with low PONV incidence, but had a trend to save propofol
and opioid dose. Therefore, we recommend that the
regimen is practicable to patients undergoing LC.
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